Though in SCLC > 90% of the patients harbor Tumor Protein 53 (TP53) gene mutations [3], its mutational load in NSCLC with >25% is also frequently observed [17] and might even level to >30% in ALK, ROS1 and RET mutated patients [14]. This evidence concerns the gene TP53 and small cell lung carcinoma.